# Redesign Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/redesign-health

- Industry: Business Support Services
- Headquarters: New York, US
- Website: www.redesignhealth.com
- Total disclosed funding: $315M
- Latest round: Series C (Sep 13, 2022)
- Investors on record: 12

## About

Based in New York, US, and founded in 2018 by its CEO, Brett Shaheen, Redesign Health Inc., operates as a provider of various support services that include technologies, tools, and insights for healthcare start-ups. In September 2022, Redesign Health raised USD 65 million in series C funding led by General Catalyst Partners, with participation from other investors, UPMC Enterprises, TriplePoint Capital, Samsung NEXT Ventures, Euclidean Capital, Eden Global Partners, and CVS Health Ventures. As of 2022, the company has offered services to more than 30 healthcare businesses like Anomaly, DUOS, Calibrate, Jasper, HealthQuarters, The Medicare, and many more. In December 2024, Redesign Health Inc. raised USD 175 million in venture funding from new investors Declaration Partners and True North Advisors, with participation from returning investor Euclidean Capital.

The company offers ideating, building, and scaling solutions for healthcare companies that serve in fields including cancer care, teleradiology, senior care, COVID-19 testing, and metabolic health. The company’s support services include product design, engineering, user research, marketing, sales, and compliance solutions.

The company plans to use the September 2022 funding to build out its team and technology.

## Funding rounds

- Series C, Sep 13, 2022, $65M — General Catalyst Partners, TriplePoint Capital, UPMC Enterprises, Samsung NEXT Ventures, Euclidean Capital, Declaration Capital, Eden Global Partners, CVS Health Ventures
- Series B, Mar 25, 2021, $250M — Centre Street Partners, RiverPark Advisors, blisce/, Declaration Capital, General Advance

## Investors

- Centre Street Partners (https://capitalatlas.ai/funds/centre-street-partners) — Series B
- RiverPark Advisors (https://capitalatlas.ai/funds/riverpark-advisors) — Series B
- blisce/ (https://capitalatlas.ai/funds/blisce) — Series B
- Declaration Capital — Series B, Series C
- General Advance (https://capitalatlas.ai/funds/general-advance) — Series B
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series C
- TriplePoint Capital (https://capitalatlas.ai/funds/triplepoint-capital) — Series C
- UPMC Enterprises (https://capitalatlas.ai/funds/upmc-enterprises) — Series C
- Samsung NEXT Ventures (https://capitalatlas.ai/funds/samsung-next-ventures) — Series C
- Euclidean Capital — Series C
- Eden Global Partners (https://capitalatlas.ai/funds/eden-global-partners) — Series C
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series C